Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Lisa Gill
JPM
Lisa Gill
Wall Street Analyst
★★★☆☆
#1751
on 13Foresight · ranked by our own returns
56%
Success Rate
-2.9%
Average Return
22 of 39 calls profitable · -18.6% vs benchmark
📈 Across the calls we could measure, roughly 56% of Lisa Gill's ratings turned a profit when each position was held for 2 year — averaging -2.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

53 Buy 23 Hold 3 Sell
Lisa's Stock Coverage 37 ratings · 2026-06-20
Company Date Position Consensus Price Target 2-Yr Return
ELV
Elevance Health
Jun 08, 2026 BUY Strong Buy
+10.9% avg upside
32 analysts
$476.00
22.58% Upside
-6.7%
UNH
UnitedHealth
Jun 08, 2026 BUY Strong Buy
+2.3% avg upside
35 analysts
$466.00
16.15% Upside
-0.8%
HUM
Humana
Jun 08, 2026 HOLD Buy
-11.2% avg upside
34 analysts
$316.00
12.41% Downside
+1.7%
CVS
CVS Health
May 27, 2026 BUY Strong Buy
+3.2% avg upside
38 analysts
+6.8%
LFST
Lifestance Health Group
May 18, 2026 HOLD Strong Buy
+8.4% avg upside
14 analysts
$9.00
0.13% Upside
+10.4%
CI
Cigna
May 15, 2026 BUY Strong Buy
+24.2% avg upside
29 analysts
+0.5%
MCK
McKesson
May 08, 2026 BUY Strong Buy
-2.2% avg upside
27 analysts
$1015.00
35.18% Upside
+5.3%
DGX
Quest Diagnostics
May 06, 2026 HOLD Buy
-12.4% avg upside
33 analysts
$220.00
12.76% Upside
+4.6%
OPCH
Option Care Health
May 04, 2026 BUY Strong Buy
+34.7% avg upside
20 analysts
$33.00
50.16% Upside
+2.7%
AGL
Agilon Health
May 04, 2026 SELL Buy
-59.5% avg upside
26 analysts
$21.00
81.60% Downside
-322.4%
CAH
Cardinal Health
May 04, 2026 HOLD Strong Buy
-12.7% avg upside
29 analysts
$215.00
2.97% Downside
+14.8%
PGNY
Progyny
Mar 18, 2026 HOLD Strong Buy
+11.9% avg upside
14 analysts
$26.00
0.32% Downside
+45.1%
TDOC
Teladoc
Mar 13, 2026 HOLD Buy
+257.6% avg upside
37 analysts
$7.00
13.28% Downside
+32.0%
OMDA
Omada Health, Inc.
Mar 12, 2026 BUY Strong Buy
+32.0% avg upside
11 analysts
$26.00
47.46% Upside
+24.7%
MDLN
Medline
Mar 10, 2026 BUY Strong Buy
+42.9% avg upside
26 analysts
$53.00
47.43% Upside
-16.2%
PRVA
Privia Health Group
Mar 06, 2026 BUY Strong Buy
+33.8% avg upside
26 analysts
$35.00
47.92% Upside
-7.0%
GDRX
GoodRx Holdings
Feb 26, 2026 HOLD Buy
+387.3% avg upside
28 analysts
+31.2%
LH
Labcorp Holdings
Feb 18, 2026 BUY Strong Buy
+1.8% avg upside
36 analysts
$330.00
29.00% Upside
-7.8%
COR
Cencora
Feb 10, 2026 BUY Buy
+14.6% avg upside
43 analysts
$419.00
54.19% Upside
-22.7%
ALHC
Alignment Healthcare
Dec 17, 2025 BUY Strong Buy
+1.2% avg upside
19 analysts
$23.00
5.15% Upside
-4.4%
AVAH
Aveanna Healthcare Holdings
Sep 18, 2025 HOLD Buy
+16.5% avg upside
17 analysts
$10.00
28.30% Upside
-10.9%
ACH
Accendra Health
Aug 27, 2025 SELL Hold
+439.4% avg upside
17 analysts
$6.00
85.84% Upside
+57.3%
CON
Concentra Group Holdings Parent, Inc.
Aug 21, 2025 BUY Strong Buy
+10.0% avg upside
9 analysts
$31.00
8.46% Upside
+14.1%
WAY
Waystar Holding Corp.
Jun 06, 2025 BUY Strong Buy
+105.7% avg upside
29 analysts
-54.9%
SGRY
Surgery Partners
May 16, 2025 HOLD Strong Buy
+68.4% avg upside
18 analysts
$27.00
85.59% Upside
-36.8%
USPH
US Physical Therapy
Mar 19, 2025 BUY Strong Buy
+44.4% avg upside
12 analysts
$110.00
73.75% Upside
-13.9%
PACS
PACS Group Inc
Dec 17, 2024 HOLD Strong Buy
+19.4% avg upside
9 analysts
$18.00
50.76% Downside
+152.6%
INNV
InnovAge Holding
Dec 17, 2024 SELL Hold
-18.6% avg upside
12 analysts
$5.00
44.29% Downside
-74.5%
CNC
Centene
Nov 12, 2024 HOLD Buy
+8.6% avg upside
28 analysts
$80.00
31.17% Upside
+3.5%
ARDT
Ardent Health Partners, Inc.
Aug 30, 2024 HOLD Buy
+53.2% avg upside
16 analysts
$19.00
113.15% Upside
-50.4%
HCA
HCA Healthcare
Aug 09, 2024 HOLD Buy
+14.7% avg upside
35 analysts
$379.00
1.07% Upside
+8.9%
UHS
Universal Health
Aug 09, 2024 HOLD Buy
+50.5% avg upside
22 analysts
$226.00
60.08% Upside
-33.8%
THC
Tenet Healthcare
Aug 09, 2024 BUY Strong Buy
+25.9% avg upside
26 analysts
$172.00
0.31% Downside
+18.9%
MOH
Molina Healthcare
Aug 09, 2024 BUY Buy
+13.8% avg upside
25 analysts
$378.00
93.57% Upside
-40.8%
HSIC
Henry Schein
Aug 09, 2023 HOLD Buy
+7.4% avg upside
25 analysts
$83.00
3.86% Upside
-14.8%
CLOV
Clover Health Investments
Jul 12, 2021 SELL Hold
-29.7% avg upside
9 analysts
$9.00
80.08% Upside
+90.5%
EVH
Evolent Health
Aug 05, 2016 BUY Strong Buy
+123.4% avg upside
19 analysts
$26.00
478.99% Upside
·
🔒 32 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Lisa Gill — Frequently Asked Questions
How accurate are Lisa Gill's stock ratings?
Based on the calls 13Foresight could measure, about 56% of Lisa's ratings were profitable over a one-year hold, with an average return of -3.0% per rating, or -13.2% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Lisa ranked on 13Foresight?
Lisa Gill is currently ranked #1751 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Lisa cover?
Lisa most recently has ratings on ELV, UNH, HUM, CVS, LFST, CI, MCK, DGX, OPCH, AGL, CAH, PGNY and 25 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.